A Study to Evaluate the Diagnostic Efficacy of DaTSCAN ™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

Conditions:   Parkinsonian Syndrome;   Parkinson Disease(PD);   Multiple System Atrophy (MSA);   Progressive Supranuclear Palsy (PSP) Intervention:   Drug: DaTSCAN™ Ioflupane (123I) Injection Sponsors:   GE Healthcare;   PPD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials